Literature DB >> 25274232

Epithelioid inflammatory myofibroblastic sarcoma responsive to surgery and an ALK inhibitor in a patient with panhypopituitarism.

Kotomi Kurihara-Hosokawa1, Isao Kawasaki, Anna Tamai, Yoko Yoshida, Yosuke Yakushiji, Hiroki Ueno, Mariko Fukumoto, Hiroko Fukushima, Takeshi Inoue, Masayuki Hosoi.   

Abstract

We encountered a case of epithelioid inflammatory myofibroblastic sarcoma (EIMS) originating from an abdominal organ that rapidly regrew twice. The patient underwent two surgeries. Large tumors grew within three months after the second surgery. The patient subsequently received chemotherapy with an anaplastic lymphoma kinase (ALK) inhibitor. Although EIMS has a poor prognosis, the patient continues to be alive with disease 14 months after surgical treatment and the administration of the ALK inhibitor.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25274232     DOI： 10.2169/internalmedicine.53.2546

Source DB:  PubMed          Journal:  Intern Med        ISSN： 0918-2918            Impact factor:   1.271


  7 in total

1.  Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.

Authors:  Xuemei Du; Ying Gao; Hongyu Zhao; Bin Li; Weimin Xue; Daye Wang
Journal:  Oncol Lett       Date:  2018-04-18       Impact factor: 2.967

Review 2.  Epithelioid inflammatory myofibroblastic sarcoma with VCL-ALK fusion of central nervous system: case report and brief review of the literature.

Authors:  Shefali Chopra; Nolan Maloney; Wei Lien Wang
Journal:  Brain Tumor Pathol       Date:  2021-11-06       Impact factor: 3.298

Review 3.  Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature.

Authors:  Qiuyu Liu; Yunzhen Kan; Yuewu Zhao; Hui He; Lingfei Kong
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 4.  Pulmonary epithelioid inflammatory myofibroblastic sarcoma with multiple bone metastases: case report and review of literature.

Authors:  Xinge Fu; Juhong Jiang; Xiao-ying Tian; Zhi Li
Journal:  Diagn Pathol       Date:  2015-07-16       Impact factor: 2.644

5.  Metastatic Anaplastic Lymphoma Kinase-1 (ALK-1)-Rearranged Inflammatory Myofibroblastic Sarcoma to the Brain with Leptomeningeal Involvement: Favorable Response to Serial ALK Inhibitors: A Case Report.

Authors:  Cai Yuan; Muchou J Ma; John V Parker; Tarek M Mekhail
Journal:  Am J Case Rep       Date:  2017-07-17

Review 6.  Inflammatory Myofibroblastic Tumour: State of the Art.

Authors:  Louis Gros; Angelo Paolo Dei Tos; Robin L Jones; Antonia Digklia
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

7.  Incomplete Intestinal Obstruction Caused by a Rare Epithelioid Inflammatory Myofibroblastic Sarcoma of the Colon: A Case Report.

Authors:  Yanjun Bai; Maofen Jiang; Wenjie Liang; Feng Chen
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.